Sheng Wan

Discovery of the First Selective IDO2 Inhibitor As Novel Immunotherapeutic Avenues for Rheumatoid Arthritis.

Qihua Zhu, Yi Zou, Zhaoxing Chu, 2022, Journal of medicinal chemistry.

Dual‐target synergistic antithrombotic mechanism of a dabigatran etexilate analogue (HY023016)

Guoqing Gong, Yungen Xu, Shuang Cui, 2022, Clinical and experimental pharmacology & physiology.

The potential of regulatory T cell-based therapies for alopecia areata

Wen Xu, Xiuzu Song, Bo Xie, 2023, Frontiers in Immunology.

Novel potential therapeutic targets of alopecia areata

Xiuzu Song, Bo Xie, Sheng Wan, 2023, Frontiers in Immunology.

Role of neurogenic inflammation in the pathogenesis of alopecia areata

Yetan Shi, Sheng Wan, Xiuzu Song, 2024, The Journal of dermatology.